NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cancer Prevention & Research Institute of Texas

Cancer Prevention & Research Institute of Texas

Austin, Texastexas.gov

Overview

Cancer Prevention & Research Institute of Texas is a Texas state agency that funds cancer research, prevention programs, and invests in early-stage oncology companies to accelerate the development of new cancer treatments and technologies.

Year Founded

2007

Portfolio Companies

13

Website

texas.gov

Investments

Cancer Prevention & Research Institute of Texas investments
CompanyDateStageLead
ImmunoSentryDec 2025GrantCo-investor
CrossBridge BioNov 2025GrantCo-investor
NovaScan Inc.Nov 2025GrantCo-investor
EMPIRI INC.Nov 2025GrantLead
Allterum TherapeuticsJun 2025GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersAustin, Texas
Year Founded2007

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.